Slides
Page 1
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben
Page 2
2026 July 30, 2026 Q2 ANDREAS NIEDERMAIER, CEO ANDREAS LÖSLER, CFO
Page 3
CAUTIONARY NOTE REGARDING FORWARD - LOOKING STATEMENTS This presentation contains forward - looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available information and present estimates. They are subject to a multitude of uncertainties and risks. Actual business development may therefore differ materially from what has been expected. Beyond disclosure requirements stipulated by law, Alzchem does not undertake any obligation to update forward - looking statements. Unless stipulated otherwise, all values are rounded up or down in accordance with the commercial rounding practices. Please note that differences can result from the use of rounded amounts and percentages. DISCLAIMER
Page 4
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q2 2026
Page 5
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben HIGHLIGHTS Successful first half 2026 – all KPIs above prior year and on expected level © Alzchem Group AG / June 2026 ✓ ✓ ✓ 5 Strong performance on group level : + 6% revenue growth + 14% EBITDA growth Volume and price growth in Specialty Chemicals Stable development in Basics & Intermediates Phased commissioning of new nitroguanidine plant in Germany has started successfully EUR 100m new growth financing with banks Outlook confirmed Sales and EBITDA on expected growth path Refurbishment of carbide furnace on finishing line
Page 6
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben USA EXPANSION @ BUSHY PARK Alzchem Establishes Nitroguanidine Production in the US Key highlights • Strategic site decision: Bushy Park (Berkeley County, South Carolina) • Long term lease contract • Supported by US government grant and state - level incentives Project status ✓ Site selection completed (key milestone achieved) ✓ Engineering and detailed costing initiated • Contract finalization with US government ongoing • Planned construction start: 2027 • Planned production start: 2029 © Alzchem Group AG / June 2026 6 Two - pillar production strategy Production of key raw materials Nitroguanidine production plant Ensures: Supply chain resilience Strengthened regional presence Why Bushy Park? • Well established chemical park with existing modern infrastructure • Access to utilities, industrial services and skilled workforce • Strong logistics (incl. Port of Charleston) • Support from state and local authorities • Space to grow © Bushy Park
Page 7
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q2 2026
Page 8
BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of specialty chemicals.
Page 9
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BASICS & INTERMEDIATES SEGMENT ( in M €) Sales and EBITDA development on expected level with one - offs 9 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 3.1 1.8 4.1 0.1 1.2 3.8 0.5 0.3 - 0.3 - 125.9% SALES EBITDA 1 - 6 2025 1 - 6 2026 1.3 0.0 - 101.5% 1 - 6 2025 1 - 6 2026 78.2 75.4 - 3.7% SALES EBITDA COMMENTS SALES ANALYSIS • H1 revenue slightly below prior year • Weak demand in agriculture and pharma business • Continued aggressive price pressure from Asian competitors • Metallurgical business showed first signs of stabilization in Q2 • EBITDA impacted by one - off furnace refurbishment • Inventories reduced significantly after planned stock build - up in 2025 + 11.5% - 2.1% - 0.8% DELTA Q2 DELTA 01 - 06 - 2.2% - 1.0% - 0.4% Volume Price Currency Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 41.8 40.9 41.9 42.6 35.6 43.3 33.5 36.7 38.7 +8.6% © Alzchem Group AG / June 2026
Page 10
SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high - quality specialty chemical ingredients with strong growth perspectives.
Page 11
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben SPECIALTY CHEMICALS SEGMENT ( in M €) Ingredients for Specialty Applications push Sales and EBITDA 11 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 85.8 80.4 89.0 94.5 100.1 87.0 97.2 105.3 109.0 +8.8% Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 22.8 21.7 26.7 26.0 27.9 24.1 28.8 31.5 32.6 +17.0% SALES EBITDA 1 - 6 2025 1 - 6 2026 53.9 64.1 +18.9% 1 - 6 2025 1 - 6 2026 194.6 214.3 +10.1% SALES EBITDA COMMENTS SALES ANALYSIS • Specialty Chemicals outperformed prior year and is the expected key growth driver • H1 revenue increased by 10% to EUR 214m, driven by higher volumes and prices • Main growth areas: Human Nutrition, Defense and Custom Manufacturing • EBITDA rose by 19% to EUR 64m, supported by product mix and scale effects • EBITDA margin improved from 27.7% to 29.9%. • Q2 stand alone confirmed the positive trend with revenue up 8.8% and EBITDA up 17% year - on - year + 2.8% + 6.5% - 0.5% DELTA Q2 DELTA 01 - 06 + 4.6% + 7.4% - 1.9% Volume Price Currency © Alzchem Group AG / June 2026
Page 12
OTHER & HOLDING The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers.
Page 13
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OTHER & HOLDING SEGMENT ( in M €) Regulated grid fees impact sales and result 13 SALES EBITDA 1 - 6 2025 1 - 6 2026 0.4 - 0.3 - 187.1% 1 - 6 2025 1 - 6 2026 14.7 14.3 - 2.6% SALES EBITDA COMMENTS • H1 revenue broadly stable year - on - year with slight decline driven by lower electricity grid fee pass - throughs • EBITDA effected by energy regulatory effects • Q2 revenue increased slightly by 6.5% Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 8.5 7.7 8.1 7.5 7.1 7.0 6.6 6.7 7.6 +6.5% © Alzchem Group AG / June 2026 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 0.8 1.1 - 0.7 0.3 0.1 0.6 - 0.3 0.2 - 0.5 - 1,157.5%
Page 14
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FINANCIAL OVERVIEW 14 • Sales increased to EUR 304m, while EBITDA margin improved from 19.6% to 21.2% • Increased volumes and price increases as key drivers for positive sales trend • Material expenses below prior year resulting from reduced carbide production during furnace renovation • Higher sales portion of specialty products combined with sustained cost discipline resulted in a substantial improvement in EBITDA and EBITDA margin • Higher depreciation and amortization charges reflect the increased level of investment activity • Reduced financial result mainly resulting from non - cash interest impacts • Net result and earnings per share follow strong operating performance – Increased by 14% © Alzchem Group AG / June 2026 All KPI above prior year – net income follows EBITDA growth Q2 Q2 2025 2026 2025 2026 1 - 6 1 - 6 SALES (in M€) 142.9 155.2 +8.7% 287.6 303.9 +5.7% EBITDA (in M€) 29.1 32.2 +10.7% 56.5 64.5 +14.2% EBITDA margin (in %) 20.4% 20.7% +0.4 pp 19.6% 21.2% +1.6 pp Earnings per Share (in €) 1.57 1.66 +5.8% 3.01 3.43 +14.0% qoq % Alzchem Group yoy % SALES ANALYSIS DELTA Q2 DELTA 01 - 06 Volume +5,1% +2,2% Price +4,2% +4,9% Currency -0,6% -1,4%
Page 15
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BALANCE SHEET & CASHFLOW CAPEX and new financing structure with material impact on balance sheet © Alzchem Group AG / June 2026 15 • Increase in balance sheet tota l resulting from increased CAPEX • Reduction in stock level – carbide stock reduced during furnace refurbishment • EUR 50m debt increase after successful new bank refinancing of EUR 100m • Customer contributions with EUR 42m lower impact on operating cash flow, but positive development of net working capital • Investing cash flow increased significantly year - on - year driven by growth. • Free cash flow turned negative year - on - year, driven by significantly higher growth investments despite strong operating cash flow • Financial cashflow impacted by new financing structure and dividend payments COMMENTS Balance sheet KPIs (T€) 31.12.2025 30.06.2026 Deviation Balance sheet total 617,679 674,112 56,433 9.1% Inventories 116,004 110,039 5,965 - -5.1% Equity 258,231 271,917 13,686 5.3% Equity ratio 41.8% 40.3% -1.5 pp -0.6% Liabilities to Banks 41,118 87,990 46,872 114.0% Cash and cash equivalents 71,720 65,695 6,026 - -8.4% Net financial debt (-) / asset (+) 30,602 22,295 - 52,898 - -172.9% Cashflow KPIs (T€) 1 - 6 2025 1 - 6 2026 Deviation Operating Cashflow 71,238 50,704 20,534 - -28.8% Investing Cashflow 40,495 - 81,226 - 40,730 - 100.6% Free Cashflow 30,743 30,522 - 61,264 - -199.3% Financial Cashflow 27,338 - 24,440 51,778 189.4% Net increase in cash 3,404 6,082 - 9,486 - -278.7% Cash / Assets Other receivables Contract liabilities 67.5 93.2 25.7 KPI impact of nitroguanidine expansion in total on balance sheet in M €
Page 16
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUTLOOK 2026 ( in M €) Ongoing growth in sales and EBITDA on expected level 16 COMMENTS Outlook for 2026 confirmed Major assumptions are still valid • No significant impact of the Iran conflict; long - term disruption of global supply chains is not included in the outlook • Possible cost increases shall be passed through to customers • First quantities from new NQ - plant will be delivered in H2 2026 Sales Growth • Growth mainly coming from ingredients in segment Specialty Chemicals • Basics & Intermediates: Sales remain on previous year’s level • Organic growth, no acquisitions • Ac celerated sales in Q2 could lead to a modestly lower performance in Q3 2026 EBITDA Growth • Further increase in specialty chemical sales will increase EBITDA as well • Impact from carbide furnace maintenance as expected 2020 FC 2021 53.8 Stable to s lightly rising 57.0 R ising to strong rising 2025 126.0 FC 2026 116.5 +8% 2025 600.0 FC 2026 562.1 +7% SALES EBITDA growth to approx. 600 .0 M € growth to approx. 126 M € © Alzchem Group AG / June 2026
Page 17
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FINANCIAL CALENDAR Upcoming dates* 17 *subject to change Financial calender ALL DATES AT A GLANCE JUL 30 2026 Half - year Financial Report 2026 SEP 1 2026 COMMERZBANK and ODDO BHF Corporate Conference, Frankfurt SEP 8 2026 Berenberg Food Ingredients & Chemicals Conference, London SEP 23 2026 Berenberg and Goldman Sachs German Corporate Conference, Munich SEP 24 2026 Baader Investment Conference, Munich OCT 29 2026 Quarterly Statement 3rd Quarter 2026 NOV 23 - 24 2026 Deutsches Eigenkapitalforum , Frankfurt DEC 1 2026 Berenberg European Conference, Fairmont London DEC 10 2026 MPCM Exclusive Company Evening, Frankfurt
Page 18
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FEEDBACK We appreciate your feedback 18 Were your expectations met? Are you missing any content? WE APPRECIATE YOUR FEEDBACK! Link QR - Code
Page 19
AGILE SCIENCE PURE RESULTS www.alzchem.com Investor Relations T +49 8621 86 - 2888 F +49 8621 86 - 502888 ir@alzchem.com
Page 20
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q2 2026
Page 21
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben KPI IMPACT OF CUSTOMER GRANTS Timing and effects on balance sheet and P&L 21 © Alzchem Group AG / June 2026 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 EST KEY EFFECTS 1 EST CASH 2 1) Only customer investment contribution / 2) Based on our current best estimate and ongoing negotiations contract liablities other receiveables Sales / EBITDA effect receivables liabilities Sales / EBITDA effect KPI EFFECTS 2025/2026 Cash / Assets ↑ Other receivables ↑ Equity → Contract liabilities ↑ Equity ratio ↓ Sales → EBITDA → KPI EFFECTS 2027 et seq. Cash / Assets → Other receivables ↓ Equity ↑ Contract liabilities ↓ Equity ratio ↑ Sales ↑ EBITDA ↑ Cash / Assets Other receivables Contract liabilities 67.5 93.2 25.7 2024 2025 2026 2027 2028 2029 EST own contribution TOTAL EFFECTS in M €
Page 22
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BALANCE SHEET Alzchem Group 22 ALZCHEM GROUP (IN T€) 31.12.2025 30.06.2026 Deviation Intangible assets 3,530 3,784 255 7.2% Tangible assets 276,980 328,868 51,887 18.7% Investment properties Right of use (assets) 2,992 2,124 -867 -29.0% Investments accounted for using the equity method Financials assets 6 6 Trade receivables Other receivables 21,801 16,160 -5,641 -25.9% there of Deferred tax assets for pensions provisions Deferred tax assets 15,711 14,871 -840 -5.3% SUM NON-CURRENT ASSETS 321,019 365,813 44,794 14.0% Inventories 116,004 110,039 -5,965 -5.1% Trade receivables 73,416 95,573 22,157 30.2% Financial assets 0 0 0 -209.9% Other receivables 35,201 36,665 1,465 4.2% Income tax receivables 319 327 8 2.6% Cash and cash equivalents 71,720 65,695 -6,026 -8.4% Assets classified as held for sale Other assets SUM CURRENT ASSETS 296,660 308,299 11,639 3.9% SUM ASSETS 617,679 674,112 56,433 9.1% © Alzchem Group AG / June 2026 ALZCHEM GROUP (IN T€) 31.12.2025 30.06.2026 Deviation Share capital 101,763 101,763 RETAINED EARNINGS (+) / LOSS (-) 232,111 245,592 13,480 5.8% Other comprehensive income -12,398 -12,271 128 -1.0% Own shares -4,111 -4,114 -3 0.1% SHARE TO THE SHAREHOLDERS 256,296 269,897 13,601 5.3% Non-controlling interests 1,934 2,020 85 4.4% SUM EQUITY 258,231 271,917 13,686 5.3% Provisions for pensions 88,239 88,662 424 0.5% Other provisions 18,981 20,156 1,175 6.2% Loans 34,750 81,583 46,834 134.8% Finance lease liabilities 1,239 499 -740 -59.7% Trade liabilities 14 -14 -100.0% Contract liabilities 88,099 87,119 -980 -1.1% Other liabilities 492 702 210 42.6% Deferred tax liabilities 8,730 9,479 749 8.6% SUM NON-CURRENT LIABILITIES 240,543 288,200 47,657 19.8% Other provisions 7,190 5,299 -1,891 -26.3% Loans 6,368 6,407 38 0.6% Finance lease liabilities 1,874 1,734 -140 -7.5% Finance liabilities 0 0 Trade liabilities 51,726 48,341 -3,385 -6.5% Contract liabilities 2,433 6,033 3,600 148.0% Other liabilities 38,340 37,448 -892 -2.3% Income tax liabilities 10,973 8,732 -2,241 -20.4% SUM CURRENT LIABILITIES 118,904 113,994 -4,911 -4.1% Sum EQUITY AND LIABILITIES 617,679 674,112 56,433 9.1%
Page 23
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben PENSION ACCOUNTING (IFRS) Alzchem Group (M €) 23 PENSION PROVISION 31.12.2025 +0.1 SERVICE COSTS +1.8 NET INTEREST COSTS - 1.5 PENSION PAYMENTS 0.0 PENSION REMEASURE - MENTS PENSION PROVISION 30.06.2026 - 7.7 DEFERRED TAX ASSETS PENSION LIABILITY 30.06.2026 88.2 88.7 81.0 +0.5% BALANCE SHEET P&L CASHFLOW IN FINANCIAL STATEMENT EBITDA (PERSONELL EXPENSES) FINANCIAL RESULT OCI © Alzchem Group AG / June 2026 • Interest rates remained unchanged at 4.1% • Pension payments develop as expected with 1.5 M € - pension obligation has a long maturity with approx. 30 years payout period
Page 24
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben INCOME STATEMENT Alzchem Group 24 ALZCHEM GROUP (IN T€) Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Deviation (Q2) Revenue 144,680 142,879 137,266 137,290 148,653 155,250 12,370 9% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 11,436 3,433 624 545 4,143 -11,145 -14,578 -425% Other income 5,263 5,006 3,806 9,266 7,339 6,038 1,032 21% Raw materials and consumables used -64,236 -47,293 -43,769 -42,989 -53,148 -39,986 7,306 -15% Employee benefits expense -41,150 -44,894 -43,245 -44,322 -44,117 -47,660 -2,766 6% Other expense -28,632 -30,036 -24,957 -29,494 -30,583 -30,297 -261 1% EBITDA 27,362 29,096 29,724 30,296 32,286 32,199 3,103 11% Depreciation expense -6,552 -6,435 -6,655 -7,007 -6,701 -7,494 -1,059 16% Impairment EBIT 20,810 22,662 23,069 23,290 25,585 24,706 2,044 9% Investment income Other interest and similar income 712 626 819 1,082 381 175 -451 -72% Other interest and similar expense -1,278 -1,284 -1,254 -1,314 -1,330 -1,592 -307 24% Financial result -567 -658 -436 -232 -948 -1,417 -759 115% Result from associates Result from ordinary business 20,243 22,003 22,634 23,057 24,637 23,289 1,286 6% Taxes on income and profit -5,607 -6,128 -6,297 -6,276 -6,636 -6,464 -337 5% thereof income tax -4,537 -6,330 -5,550 -6,040 -5,754 -5,741 589 -9% thereof change from deferred taxes -1,070 202 -748 -235 -882 -724 -926 -458% Annual result 14,636 15,876 16,337 16,782 18,001 16,825 949 6% thereof minority interests 43 43 43 43 43 43 thereof shares held by shareholders 14,594 15,833 16,294 16,739 17,958 16,782 949 6% Result per share in EUR 1.44 € 1.57 € 1.61 € 1.66 € 1.77 € 1.66 € © Alzchem Group AG / June 2026
Page 25
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben INCOME STATEMENT Alzchem Group 25 ALZCHEM GROUP (IN T€) Q2 2025 Q2 2026 Deviation (QoQ) YTD Jun.2025 YTD Jun.2026 Deviation (YoY) Revenue 142,879 155,250 12,370 8.7% 287,559 303,902 16,343 5.7% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 3,433 -11,145 -14,578 -424.6% 14,869 -7,002 -21,872 -147.1% Other income 5,006 6,038 1,032 20.6% 10,269 13,378 3,108 30.3% Raw materials and consumables used -47,293 -39,986 7,306 -15.4% -111,528 -93,135 18,393 -16.5% Employee benefits expense -44,894 -47,660 -2,766 6.2% -86,044 -91,777 -5,734 6.7% Other expense -30,036 -30,297 -261 0.9% -58,667 -60,880 -2,213 3.8% EBITDA 29,096 32,199 3,103 10.7% 56,459 64,486 8,027 14.2% Depreciation expense -6,435 -7,494 -1,059 16.5% -12,987 -14,195 -1,208 9.3% Impairment 0 0 0 0 0 0 EBIT 22,662 24,706 2,044 9.0% 43,471 50,291 6,819 15.7% Investment income 0 0 0 0 0 0 Other interest and similar income 626 175 -451 -72.0% 1,338 557 -781 -58.4% Other interest and similar expense -1,284 -1,592 -307 23.9% -2,563 -2,922 -359 14.0% Financial result -658 -1,417 -759 115.2% -1,225 -2,365 -1,140 93.1% Result from associates 0 0 0 0 0 0 Result from ordinary business 22,003 23,289 1,286 5.8% 42,247 47,926 5,679 13.4% Taxes on income and profit -6,128 -6,464 -337 5.5% -11,735 -13,100 -1,366 11.6% thereof income tax -6,330 -5,741 589 -9.3% -10,867 -11,495 -628 5.8% thereof change from deferred taxes 202 -724 -926 -458.2% -868 -1,606 -738 85.0% Annual result 15,876 16,825 949 6.0% 30,512 34,825 4,314 14.1% thereof minority interests 43 43 0 0.0% 85 85 0 0.0% thereof shares held by shareholders 15,833 16,782 949 6.0% 30,426 34,740 4,314 14.2% Result per share in EUR 1.57 € 1.66 € 0 5.8% 3.01 € 3.43 € 0 14.0% © Alzchem Group AG / June 2026
Page 26
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben CASHFLOW STATEMENT Alzchem Group 26 © Alzchem Group AG / June 2026 CASHFLOW (IN M€) Q2 2025 Q2 2026 1 - 6 2025 1 - 6 2026 Consolidated earnings before taxes 22,003 23,289 42,247 47,926 Depreciation on fixed and intangible assets 6,435 7,494 12,987 14,195 Decrease in pension provisions -606 -656 -1,374 -1,488 Loss (+) / Profit (-) from the sale of non-current assets 0 -10 22 -37 Other non-cash income (-) and expenses (+) 1,997 3,138 2,268 5,462 Financial result 658 1,417 1,225 2,365 Interests & Taxes -4,138 -8,979 -7,886 -13,998 Increase (+) / Decrease (-) Net Working Capital -16,132 -15,473 -29,256 -12,512 Payments from customer grants 2,818 51,005 8,791 Cashflow from ongoing operations (Net cash flow) 21,721 13,037 71,238 50,704 Cash outflows for investments in fixed assets -27,394 -44,706 -40,534 -81,305 Cash inflows from the sale of fixed assets -1 45 39 79 Cash inflows from grants received for investments Cashflow from investing activity -27,394 -44,661 -40,495 -81,226 Free cashflow -5,673 -31,624 30,743 -30,522 Deposits (+) of bank loans long-term 80,000 80,000 Repayment (-) of bank loans long-term -2,208 -31,583 -4,416 -33,166 Deposits (+) / Repayment (-) from short-term financing lines Dividend payments -18,190 -21,260 -18,190 -21,260 Payment of reduction in leasing liabilities -478 -478 -956 -957 Payments for the acquisition of own shares (incl. transaction costs) -1 1,300 -3,605 Payments for the issue of own shares -5 -6 Payments to non-controlling interests -171 -171 Cashflow from financing activity -20,878 27,974 -27,338 24,440
Page 27
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben SEGMENT OVERVIEW BY QUARTER Alzchem Group SALES EBITDA 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q2) PY Actual Deviation PY (YOY) T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 49,299 41,848 40,927 41,929 42,638 35,605 43,309 33,539 36,666 38,684 3,079 9% 78,244 75,350 -2,894 -4% Specialty Chemicals 92,961 85,805 80,354 88,969 94,512 100,128 86,978 97,159 105,298 108,954 8,827 9% 194,639 214,252 19,613 10% Other and Holding 7,804 8,538 7,656 8,142 7,530 7,146 6,979 6,592 6,689 7,611 465 7% 14,676 14,300 -376 -3% Group Consolidation Alzchem Group 150,064 136,191 128,937 139,040 144,680 142,879 137,266 137,290 148,653 155,250 12,370 9% 287,559 303,902 16,343 6% SALES YTD Q2 2026 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q2) PY Actual Deviation PY (YOY) T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 1,802 3,055 1,827 4,142 140 1,174 3,754 549 284 -304 -1,478 -126% 1,314 -20 -1,334 -101% Specialty Chemicals 22,684 22,843 21,749 26,741 26,041 27,854 24,117 28,782 31,484 32,593 4,739 17% 53,895 64,078 10,183 19% Other and Holding 537 849 1,114 -711 307 50 596 -287 222 -533 -584 <-1.000% 358 -312 -669 -187% Group Consolidation -113 274 194 -1,717 874 18 1,257 1,253 296 443 425 >1.000% 892 739 -153 -17% Alzchem Group 24,910 27,021 24,883 28,455 27,362 29,096 29,724 30,296 32,286 32,199 3,103 11% 56,459 64,486 8,027 14% EBITDA YTD Q2 2026 © Alzchem Group AG / June 2026
Page 28
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben ALZCHEM GROUP LOCATIONS Production sites and sales companies © Alzchem Group AG / June 2026 ATLANTA (USA) SHANGHAI (CN) SCHALCHEN (GER) HART a. d. ALZ (GER) WALDKRAIBURG (GER) SUNDSVALL (SE) TROSTBERG (GER) SALES COMPANY PRODUCTION SITE Production facilities in Germany (4) and Sweden (1) and HQ in Trostberg (GER) COVENTRY (UK) BERLIN (GER)
Page 29
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben “VERBUND” – FULLY INTEGRATED BUSINESS MODEL Vertically integrated production of chemical products based on the NCN chain BENEFITS OF “VERBUND” • Full control of product quality and specifications • Lower costs • Higher financial predictability • Certainty of supply • Well positioned to address niche markets • Economies of scale • Low carbon footprint 29 GLOBAL DEVELOPMENTS AS GROWTH DRIVERS Segment Specialty Chemicals Segment Basics & Inter - mediates © Alzchem Group AG / June 2026 POPULATION GROWTH LONGER LIFE EXPECTANCY SUSTAINA - BILITY CLIMATE CHANGE SAFETY & DEFENCE
Page 30
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries 30 © Alzchem Group AG / June 2026 MAIN PRODUCTS DESCRIPTION END - MARKETS SPECIALTY CHEMICALS A nutritional additive for poultry and pigs Feed additive Creapure ® , premium brand for creatine monohydrate as ingredient in sports & health nutrition Food supplements Dietary supplement with pure creatine Food supplements Creatine for health and food applications Food supplements Plant growth regulator used in fruit production Agriculture Additive for plant protection formulations Agriculture Plant growth regulator used in fruit production Agriculture Silicon nitride powder for ceramic applications Ceramics Highly purified form of guanidine salts Pharmaceuticals / API An organic compound widely used in agriculture and pharmaceuticals Agriculture and pharmaceuticals Hardeners and accelerators in powder. paste and liquid form Hardener & Accelerator Systems for Composite Materials Various applications incl. flotation agents and pharmaceutical raw materials Mining and pharmaceuticals Intermediates for explosives and agrochemical products Agriculture. Automotive. Defense
Page 31
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries 31 MAIN PRODUCTS DESCRIPTION END - MARKETS BASICS & INTERMEDIATES Calcium carbide - based mixtures for hot metal desulphurization Steel industry Fuel for airbags. key production of the intermediate product Automotive Versatile intermediate in various markets including the pharmaceutical industry P harmaceutical Agriculture Business fields in color, agro and pharmaceutical applications Pigments P harmaceutical Reduction of methane emissions during storage of manure Agriculture Special calcium cyanamide multi - effect fertilizer Agriculture OTHER & HOLDING Operation of the Trostberg Chemical Park (companies located at the site: Alzchem, BASF, Master Builders Solution, Sika, Firme nic h, Klüh Catering, VIACTIV) Site services Other activities not included in the "Specialty Chemicals" or "Basics & Intermediates" segments © Alzchem Group AG / June 2026
Page 32
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben four two na GmbH 10.14% Staluna Trade a. s. 9.90% Löw SE 6.39% Free float 73.57% KEY SHARE DATA Share details as of July 28, 2026 32 SHAREHOLDER STRUCTURE © Alzchem Group AG / June 2026 As of June 2026: The information on the shareholders is based on the figures reported to us by them. Data regarding the free float are provided in accordance with section 5.8 of the Stoxx “DAX Equity Index Methodology Guide”. The information is based on published notifications of major holdings. Certain reported positions may reflect bank holdings for trading or hedging purposes and are not separately presented above. SHARES OUTSTANDING 10,176,335 LAST CLOSING PRICE EUR 173.30 MARKET CAPITALIZATION EUR 1,763.6 m TICKER ACT WKN A2YNT3 ISIN DE000A2YNT30 LISTING Frankfurt Stock Exchange – Prime Standard STOCK MARKET SEGMENT SDAX DESIGNATED SPONSOR LBBW ODDO BHF SE